XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
ASSETS    
Cash and cash equivalents $ 61,750,809 $ 63,655,877
Restricted cash 4,306,519 2,705,750
Account receivables, net
Other current assets, net 6,834,769 5,557
Current assets – discontinued operations 1,322,503
Loan receivables 800,000
Total current assets 73,692,097 67,689,687
Non-marketable investment, net
Non-current assets – discontinued operations 61,376
Total non-current assets 61,376
Total assets 73,692,097 67,751,063
LIABILITIES    
Accrued expenses and other payables 3,259,319 2,131,891
Current liabilities – discontinued operations 8,700,835
Advance from customers 4,306,519 2,705,750
Short term borrowings from a third party 1,550,000
Warrant liability 4,971,869
Tax payable 350,752 255,805
Total current liabilities 12,888,459 15,344,281
Total liabilities 12,888,459 15,344,281
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY    
Common stock (20,000,000 shares authorized; $0.005 par value; 1,399,675 shares issued and outstanding as of December 31, 2023;699,838 shares issued and outstanding as of December 31, 2022 respectively*) 38,491 34,992
Additional paid-in capital 95,726,623 92,526,972
Accumulated deficit (34,961,476) (39,797,696)
Accumulated other comprehensive loss (357,486)
Total shareholders’ equity 60,803,638 52,406,782
Total liabilities and shareholders’ equity $ 73,692,097 $ 67,751,063